Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
TRINTELLIX
(https://trintellix.com) 📸 Data Snapshot: June 20, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
NAV_HEADER_REPEATED_BODY TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com/resources/)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
NAV_HEADER_REPEATED_BODY TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com/request-a-rep/)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
NAV_HEADER_REPEATED_BODY TRINTELLIX (vortioxetine) for U.S. Healthcare Providers (https://trintellix.com/clinical-data/)
TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
Find safety data, clinical studies, dosing, MOA, & savings info. See Safety Info, including Boxed WARNING about Suicidality, & Full Prescribing Information.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://trintellix.com) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
SUB-PAGE (https://trintellix.com/resources/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
SUB-PAGE (https://trintellix.com/request-a-rep/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
SUB-PAGE (https://trintellix.com/clinical-data/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 7 | 0 |
| /resources/ | 7 | 0 |
| /request-a-rep/ | 7 | 0 |
| /clinical-data/ | 7 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
TRINTELLIX has 16.3 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: TRINTELLIX (trintellix.com)
TRINTELLIX operates as a high-gloss regulatory shell that satisfies legal safety requirements while withholding substantive clinical depth from the top-level crawl. It is a ‘Ghost Ship’ of authority—claiming expert backing while failing to name a single human or provide a single clickable source.
Implement Person schema for the unnamed experts mentioned in the ‘Expert Insights’ section to provide verifiable authority. Replace the duplicate homepage content on the /clinical-data/ page with actual data tables and P-values from the 6 referenced studies. Hyperlink all numerical footnotes to their respective PubMed or ClinicalTrials.gov entries to create a valid proof path. Add a unique H1 to every page to establish a clear heading hierarchy beyond safety warnings.
The site content aligns perfectly with the pharmaceutical industry, specifically targeting U.S. Healthcare Providers (HCPs) for Major Depressive Disorder (MDD) treatment. The presence of ‘vortioxetine’ and ‘Prescribing Information’ markers confirms the regulatory-heavy nature of this category.
“The score of 57 is driven by high technical failures (null schema, missing H1s) and the massive semantic drift caused by identical content across all sub-pages. While the pharmaceutical claims are likely valid under FDA scrutiny, the website's digital expression of that authority is lazy, repetitive, and lacks transparent evidence paths.”
This training module utilizes a snapshot of public data from TRINTELLIX, captured on June 20, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to TRINTELLIX: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://trintellix.com to view the most current version of its content and learn from the source what this company is about and what it offers.